Supported by

Tricuspid / Pulmonary valve

Latest tricuspid content in interventional cardiology - research, practice, and education

Endovascular treatments for complications of the tricuspid or pulmonary valve, such as the treatment for tricuspid regurgitation (TR), are at an early stage of clinical development with many novel devices being introduced each year. This topic explores the different parameters of this emerging field with information on the latest research, emerging tools, devices and techniques, vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography as well as understanding bleeding risks or patient selection. Find out more…

Filtered By
Tricuspid / Pulmonary valve

519 results

PCR's Got Talent Round 1 - Session 1

20 May 2025 – From EuroPCR 2025

Experience a diverse range of cutting-edge interventional cardiology topics in PCR's Got Talent Round 1. This session features presentations on PFO closure outcomes, plaque morphology, vascular injury treatments, microvascular disease assessment, TAVI-related coronary obstruction prediction, novel FFR surrogates, and more.

PCR's Got Talent Round 1 - Session 1

What is new in atrioventricular valves?

19 May 2025 – From EuroPCR 2025

Discover the latest advancements in atrioventricular valve interventions, including innovative transcatheter repair technologies and first-in-human experiences with novel devices.

What is new in atrioventricular valves?

New solutions for old problems

19 May 2025 – From EuroPCR 2025

Discover new solutions addressing persistent cardiovascular challenges, including novel diagnostic systems, vascular closure devices, specialized transcatheter closure technologies, and innovative stent-graft systems.

New solutions for old problems

Quadruple pulmonary vein stenting for post-ablation stenosis

28 Apr 2025

Watch this EuroIntervention image to discover how a complex case of severe pulmonary vein stenosis after atrial fibrillation ablation was successfully managed with multi-stent implantation and intravascular imaging guidance — restoring the patient’s quality of life almost immediately.

Quadruple pulmonary vein stenting for post-ablation stenosis

Pacemaker leads and tricuspid interventions: knowns and unknowns

24 Apr 2025

Watch this webinar with F. Praz, J-C. Deharo, J. Dreyfus and B. Mondésert and learn about the mechanisms and risk of interaction between pacemaker lead and the tricuspid valve, and much more!

Pacemaker leads and tricuspid interventions: knowns and unknowns

Updates in tricuspid interventions: from the procedure to follow-up

15 Apr 2025

Watch the replay of this webinar with G. Nickenig, J. Dreyfus, S. Kar and P. Lurz and learn about the follow-up results of the TRILUMINATE trial, and so much more!

Updates in tricuspid interventions: from the procedure to follow-up

Primary tricuspid regurgitation: how can we avoid high-risk surgery?

08 Apr 2025

A 70-year-old male patient presents with severe dyspnea (NYHA III) and marked leg edema, alongside a complex medical history including hypertrophic cardiomyopathy, pulmonary hypertension, and liver fibrosis.

With invasive hemodynamic measurements indicating elevated pressures and reduced cardiac output, how would you approach the treatment of this patient,...

Philipp Bartko

Author

Philipp Bartko
Varius Dannenberg

Author

Varius Dannenberg
Primary tricuspid regurgitation: how can we avoid high-risk surgery?

Two-year outcomes of transcatheter tricuspid valve edge-to-edge repair for tricuspid regurgitation: The Triluminate pivotal trial

02 Apr 2025

Alex Sticchi interviews Saibal Kar about the two-year results of the Triluminate pivotal trial, unveiled at ACC.25 in Chicago.

After revisiting the one-year findings and outlining the study design, Saibal Kar highlights key takeaways: at two years, TriClip therapy significantly reduced heart failure hospitalisations compared to medical...

Author

Saibal Kar
Alessandro Sticchi

Author

Alessandro Sticchi

Author

Saibal Kar
Two-year outcomes of transcatheter tricuspid valve edge-to-edge repair for tricuspid regurgitation: The Triluminate pivotal trial

Gore Cardioform ASD occluder implantation for late progression of TR after Triclip

12 Mar 2025

Late progression of TR following T-TEER is not uncommon and may be challenging to treat due to anatomical and technical limitations. This is the 1st report of Gore Cardioform ASD Occluder implantation to treat recurrent severe TR after T-TEER.

Gore ASD Occluder after TriClip